参考文献/References:
[1] 黄惠芝.慢性阻塞性肺疾病骨骼肌萎缩的治疗现状[J]. 临床与病理杂志 ,2017,37(4):831-834.HUANG Huizhi. Actuality of treatment of muscleatrophy in chronic obstructive pulmonary disease[J].International Journal of Pathology and ClinicalMedicine,2017,37(4):831-834.
[2] 李军民 , 白晓 , 孟茜 , 等 .COPD 患者血清降钙素原水平与肺功能的关系研究 [J].现代检验医学杂志,2018, 33(1):148-150.LI Junmin, BAI Xiao, MENG Qian, et al. Relationshipstudy on serum levels of procalcitonin and pulmonaryfunction in patients with chronic obstructivepulmonary disease[J]. Journal of Modern LaboratoryMedicine,2018,33(1): 148-150.
[3] BARREIRO E. Skeletal muscle dysfunction inCOPD: novelties in the last decade[J]. Archivos deBronconeumologia, 2017, 53(2): 43-44.
[4] DE MAS IGOR M, FANCHON E, PAPP B, et al. Mo-lecular mechanisms underlying COPD-muscle dysfunc-tion unveiled through a systems medicine approach[J].Bioinformatics (Oxford, England), 2017, 33(1): 95-103.
[5] TAIVASSALO T, HUSSAIN SNA. Contribution of themitochondria to locomotor muscle dysfunction in patientswith COPD[J]. Chest, 2016, 149(5): 1302-1312.
[6] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志 , 2013, 36(4):255-264.Chronic Obstructive Pulmonary Disease Group,Respiratory Branch, Chinese Medical Association.Guideline for diagnosis and treatment of chronicobstructive pulmonary disease (2013Revised Edition)[J].Chinese Journal of Tuberculosis and RespiratoryDiseases, 2013, 36(4):255-264.
[7] GEA J, CASADEVALL C, PASCUAL S, et al. Clinicalmanagement of chronic obstructive pulmonary diseasepatients with muscle dysfunction[J]. Journal ofThoracic Disease, 2016, 8(11): 3379-3400.
[8] BALNIS J, KORPONAY T C, JAITOVICH A.AMP-Activated protein kinase (AMPK) at the cross-roads between CO 2 retention and skeletal muscledysfunction in chronic obstructive pulmonary disease(COPD)[J]. International Journal of Molecular Scienc-es, 2020, 21(3): 955.
[9] JAITOVICH A, BARREIRO E. Skeletal muscledysfunction in chronic obstructive pulmonary disease.what we know and can do for our patients[J]. AmericanJournal of Respiratory and Critical Care Medicine,2018, 198(2): 175-186.
[10] LIU Shihfeng, KUO Hochang, TSENG C W, etal. Leukocyte mitochondrial DNA copy numberis associated with chronic obstructive pulmonarydisease[J]. PLoS One, 2015, 10(9): e0138716.
[11] FALAH M, HOUSHMAND M, NAJAFI M, et al.The potential role for use of mitochondrial DNA copynumber as predictive biomarker in presbycusis[J].Therapeutics and Clinical Risk Management, 2016,12(3): 1573-1578.
[12] KONOKHOVA Y, SPENDIFF S, JAGOE R T, et al.Failed upregulation of TFAM protein and mitochondrialDNA in oxidatively deficient fibers of chronicobstructive pulmonary disease locomotor muscle[J].Skeletal Muscle, 2016, 6(1): 10.
[13] 户元元 , 李亚 , 李素云 . 氧化应激在 COPD 骨骼肌功能障碍中的研究进展 [J]. 中国老年学杂志 , 2019,39(5): 1244-1247.HU Yuanyuan, LI Ya, LI Suyun. Research progress ofoxidative stress in COPD skeletal muscle dysfunction[J]. Chinese Journal of Gerontology, 2019,39(5):1244-1247.
[14] 朱木林,袁云华,刘丹,等.慢性阻塞性肺疾病合并外周骨骼肌功能障碍患者炎症因子及代谢指标的观察 [J]. 西部医学,2015,27(6):876-878.ZHU Mulin, YUAN Yunhuan, LIU Dan, et al.Inflammatory factor and metabolic indices in patientswith COPD complicated with PSM [J]. Medical Journalof West China,2015,27(6):876-878.
[15] 朱木林 , 袁云华 , 邓巍 , 等 . 慢性阻塞性肺疾病合并外周骨骼肌功能障碍患者炎性因子和代谢水平及线粒体功能的变化[J].新乡医学院学报,2015,32(5):412-414, 418.ZHU Mulin, YUAN Yunhua, DENG Wei, et al.Changes of inflammatory factor, metaboilic leveland mitochondrial function in patients with chronicobstructive pulmonary disease complicated withperipheral skeletal muscle dysfunction [J]. Journal ofXinxiang Medical University,2015,32(5):412- 414, 418.
相似文献/References:
[1]邱淑佳.慢性阻塞性肺疾病患者血清LCN1,LCN2的表达水平及临床意义[J].现代检验医学杂志,2017,32(06):67.[doi:10.3969/j.issn.1671-7414.2017.06.001]
QIU Shu-jia.Expression Levels of Serum LCN1 and LCN2
in Patients with Acute Exacerbation of Chronic Obstructive
Pulmonary Disease and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2017,32(06):67.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[2]杜 洁a,朱 娜b,李红艳a,等.幽门螺杆菌感染对慢性阻塞性肺疾病血气分析及肺功能的影响[J].现代检验医学杂志,2017,32(06):99.[doi:10.3969/j.issn.1671-7414.2017.06.001]
DU Jiea,ZHU Nab,LI Hong-yana,et al.Effect of Helicobacter Pylori Infection
on Blood Gas Analysis and Pulmonary Function
in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2017,32(06):99.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[3]李若倩,刘 云,李若然.外周血红细胞分布宽度和超敏C- 反应蛋白水平检测在慢性阻塞性肺疾病诊断中的价值分析[J].现代检验医学杂志,2020,35(03):123.[doi:10.3969/j.issn.1671-7414.2020.03.033]
LI Ruo-qian,LIU Yun,LI Ruo-ran.Value of Detecting Peripheral Blood Red Blood Cell Distribution Width and
High Sensitivity C Reactive Protein in the Diagnosis of Chromic
Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2020,35(06):123.[doi:10.3969/j.issn.1671-7414.2020.03.033]
[4]王 苗,张 萍.COPD患者血清 Cav-1及 CXCL12水平检测与并发肺动脉高压的相关性研究[J].现代检验医学杂志,2021,36(01):29.[doi:10.3969/j.issn.1671-7414.2021.01.008]
WANG Miao,ZHANG Ping.Correlation between Levels of Cav-1 and CXCL12 in Serum and Pulmonary Hypertension in Patients with COPD[J].Journal of Modern Laboratory Medicine,2021,36(06):29.[doi:10.3969/j.issn.1671-7414.2021.01.008]
[5]闫海燕,杨云秀,杨云华,等.慢性阻塞性肺疾病患者 Nrf2 基因多态性与肺功能及临床病情判断的相关性研究[J].现代检验医学杂志,2021,36(03):27.[doi:10.3969/j.issn.1671-7414.2021.03.007]
YAN Hai-yan,YANG Yun-xiu,YANG Yun-hua,et al.Study on Relevance of Nrf2 Gene Polymorphism with Pulmonary Functionand Clinical Condition Judgment in Patients with Chronic ObstructivePulmonary Disease[J].Journal of Modern Laboratory Medicine,2021,36(06):27.[doi:10.3969/j.issn.1671-7414.2021.03.007]
[6]胡小燕,郑 晓,嵇华夏,等.血清 PCT 与 BNP 水平联合检测对慢性阻塞性肺疾病急性加重期并发心力衰竭的临床诊断价值[J].现代检验医学杂志,2021,36(03):128.[doi:10.3969/j.issn.1671-7414.2021.03.029]
HU Xiao-yan,ZHENG Xiao,JI Hua-xia,et al.Clinical Diagnostic Value of Combined Detection of Serum PCT and BNPLevels in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated with Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(06):128.[doi:10.3969/j.issn.1671-7414.2021.03.029]
[7]陈志勇a,罗世林a,张 健b,等.慢阻肺患者血清IL-17,IL-27和IL-33水平表达及与不同临床分期FeNO和肺功能的相关性研究[J].现代检验医学杂志,2021,36(04):152.[doi:10.3969/j.issn.1671-7414.2021.04.033]
CHEN Zhi-yonga,LUO Shi-lina,ZHANG Jianb,et al.Expression of Serum IL-17, IL-27 and IL-33 in Patients with ChronicObstructive Pulmonary Disease and Its Correlation with FeNO and LungFunction in Different Clinical Stages[J].Journal of Modern Laboratory Medicine,2021,36(06):152.[doi:10.3969/j.issn.1671-7414.2021.04.033]
[8]王述红,邱 容,罗晓斌,等.慢性阻塞性肺疾病患者血气分析指标,FeNO,EOS%水平变化与CAT评分的相关性研究[J].现代检验医学杂志,2021,36(04):156.[doi:10.3969/j.issn.1671-7414.2021.04.034]
WANG Shu-hong,QIU Rong,LUO Xiao-bin,et al.Correlation between Changes of Blood Gas Analysis Indexes, FeNO, EOS%and CAT Score in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2021,36(06):156.[doi:10.3969/j.issn.1671-7414.2021.04.034]
[9]龙借帆a,李 翠a,高元标a,等.联合检测血清SIRT1和CTRP5水平对慢性阻塞性肺疾病急性加重期患者预后的预测价值研究[J].现代检验医学杂志,2022,37(03):162.[doi:10.3969/j.issn.1671-7414.2022.03.034]
LONG Jie-fana,LI Cuia,GAO Yuan-biaoa,et al.Prognostic Value of Combined Detection of Serum SIRT1 and CTRP5 Levels in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2022,37(06):162.[doi:10.3969/j.issn.1671-7414.2022.03.034]
[10]崔小丽,孙 宁,赵 瑞,等.艾地苯醌对癫痫大鼠模型神经元线粒体功能、能量代谢及抗氧化作用机制研究[J].现代检验医学杂志,2023,38(01):44.[doi:10.3969/j.issn.1671-7414.2023.01.009]
CUI Xiao-li,SUN Ning,ZHAO Rui,et al.Study on the Mechanism of Idebenone on Mitochondrial Function, Energy Metabolism and Antioxidation in Epileptic Rats Model[J].Journal of Modern Laboratory Medicine,2023,38(06):44.[doi:10.3969/j.issn.1671-7414.2023.01.009]